Safety and efficacy of meplazumab in healthy volunteers and COVID-19 patients: a randomized phase 1 and an exploratory phase 2 trial

por Bian, Huijie, Zheng, Zhao-Hui, Wei, Ding, Wen, Aidong, Zhang, Zheng, Lian, Jian-Qi, Kang, Wen-Zhen, Hao, Chun-Qiu, Wang, Jing, Xie, Rong-Hua, Dong, Ke, Xia, Jie-Lai, Miao, Jin-Lin, Kang, Wen, Li, Guoquan, Zhang, Di, Zhang, Mingru, Sun, Xiu-Xuan, Ding, Likun, Zhang, Kui, Jia, Junfeng, Ding, Jin, Li, Zhiqin, Jia, Yanyan, Liu, Lin-Na, Zhang, Zhe, Gao, Zhao-Wei, Du, Hong, Yao, Na, Wang, Qing, Wang, Ke, Geng, Jie-Jie, Wang, Bin, Guo, Ting, Chen, Ruo, Zhu, Yu-Meng, Wang, Li-Juan, He, Qian, Yao, Rui-Rui, Shi, Ying, Yang, Xiang-Min, Zhou, Jian-Sheng, Ma, Yi-Nan, Wang, Ya-Tao, Liang, Xue, Huo, Fei, Wang, Zhe, Zhang, Yang, Yang, Xu, Zhang, Ye, Gao, Lu-Hua, Wang, Ling, Chen, Xiao-Chun, Tang, Hao, Liu, Shuang-Shuang, Wang, Qing-Yi, Chen, Zhi-Nan, Zhu, Ping
Publicado 2021